HIMS250110C18000
- 9.69
- 0.000.00%
Hims & Hers Health Newsroom
HIMS Downgraded, Agilon Upgraded at Citi in 2025 Health Tech Review
Citi Downgrades Hims & Hers Health(HIMS.US) to Sell Rating, Raises Target Price to $25
What's Going On With Hims & Hers Health Stock?
Wall Street's Riskiest Stocks Are Melting Down as Retail Traders Face 'Day of Reckoning'
Here's Cedar Grove Capital Management's Investment Thesis for Hims & Hers Health (HIMS)
'Meta Ad Changes Threaten Telehealth's Weight Loss Boom' - The Information
Insider Sale: Chief Legal Officer of $HIMS (HIMS) Sells 30,000 Shares
Hims & Hers Health(HIMS.US) Officer Sells US$7.46 Million in Common Stock
Hims & Hers Donates $1 Million to Trump's Inauguration Fund
Why Hims & Hers Health, Inc. (NYSE:HIMS) Could Be Worth Watching
Hims & Hers Donates $1M to Trump's Inauguration
BTIG Initiates Hims & Hers Health(HIMS.US) With Buy Rating, Announces Target Price $35
Express News | Form 144 | Hims & Hers Health(HIMS.US) Officer Proposes to Sell 7.46 Million in Common Stocks
Needham Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Raises Target Price to $31
Hims & Hers Health Is Maintained at Buy by Needham
Hims & Hers Health: Undervalued Growth Potential Amidst Digital Health Expansion
Hims & Hers Health Analyst Ratings
Express News | Hims & Hers Health Inc : Piper Sandler Raises Target Price to $24 From $21
Weight Loss Drugs Can Cut Grocery Spending by up to 9%: Study
Is Hims & Hers Health a Millionaire Maker?